XML 134 R116.htm IDEA: XBRL DOCUMENT v3.21.2
Share-Based Compensation (Narrative) (Details) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares available for future grant 1,566,433    
Closing stock price (in dollars per share) $ 256.11    
Cash received from option exercises $ 10.6 $ 34.1 $ 68.1
Total tax benefit realized from stock option exercises 6.8    
Excess tax benefit from stock option exercises $ 6.5    
Deferred Stock Units      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of units/shares granted 188,000    
Weighted-average grant date fair value (in dollars per share) $ 261.95    
Cash payments made for deferred stock units $ 5.2 4.8 1.9
Unrecognized compensation costs $ 47.0    
Unrecognized compensation costs, period for recognition, years 1 year 6 months    
Fair value of deferred stock units paid $ 88.0 $ 65.4 $ 19.2
Deferred Stock Units | Minimum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting or deferral period 2 years    
Deferred Stock Units | Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting or deferral period 5 years    
Director Deferred Stock Units | Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Period after service in which to elect payment 10 years    
Market-Based Deferred Stock Unit      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting or deferral period 3 years    
Number of units/shares granted 77,251 80,215 114,929
Weighted-average grant date fair value (in dollars per share) $ 235.48 $ 275.19 $ 229.61
Time-Based Deferred Stock Unit      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of units/shares granted 110,555 123,448 169,666
Weighted-average grant date fair value (in dollars per share) $ 282.48 $ 230.92 $ 168.68
Stock Options      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting or deferral period 3 years    
Exercisable period from grant date 10 years    
Weighted average remaining contractual terms, outstanding 1 year 10 months 24 days    
Weighted average remaining contractual terms, exercisable 1 year 10 months 24 days    
Aggregated intrinsic value, outstanding $ 125.0    
Aggregated intrinsic value, exercisable 125.0    
Intrinsic value of stock options exercised 29.0 $ 65.7 $ 87.2
Cash received from option exercises $ 10.6